A study by a team of Victoria University of Wellington scientists spotlights the role of gene networks in how people respond to one of the world's most prescribed medications.
Oct 4, 2019
1
129
A University of California, Riverside, research team has come up with a new approach to targeting cancer cells that circumvents a challenge faced by currently available cancer drugs.
May 17, 2019
0
208
Doctors have criticized the General Medical Council (GMC) after The BMJ found it had investments in fast food firms, pharmaceutical companies, private medical insurers and private healthcare providers.
Mar 15, 2023
0
3
A team of researchers at Washington State University has discovered a second DNA-sensing pathway that initiates an antiviral response to foreign genetic material in human cells. In their paper published in the journal Science ...
Drug companies are working to develop a pure, more powerful version of the nation's second most-abused medicine, which has addiction experts worried that it could spur a new wave of abuse.
Dec 26, 2011
7
0
A psychiatrist specialising in sexual dysfunction caused by antidepressants is calling for greater recognition of the problems that can endure after treatment stops. Professor David Healy, writing in the Journal of the Royal ...
Jan 24, 2020
0
20
Yale researchers have discovered a "jamming signal" that blocks a powerful immune system stimulant called interleukin-18 (IL-18) from reaching tumors, including in cancers that are resistant to conventional immunotherapy ...
Jun 24, 2020
0
101
Incentives intended to stimulate the development of more treatments for rare diseases are being exploited to boost the profits of pharmaceutical companies, new research led by Bangor University shows.
Oct 21, 2016
3
94
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer's Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19.
Mar 10, 2022
0
123
A global coronavirus vaccine rollout suffered a major blow Friday as Pfizer said it would delay shipments of the jabs in the next three to four weeks due to works at its key plant in Belgium.
Jan 15, 2021
0
7
